Embion closes ASAHI led CHF 4.5M Series A Round

Embion's platform biomass processing technology enables the repurposing of food and agricultural industry by-products towards high-value, nature-derived functional ingredients. Such upcycling helps to expand food resources, supply security and sustainability with a technology that efficiently reduces the carbon footprint of food production. Embion is a Swiss industrial biotechnology and green chemistry company with global reach and impact.

"We are incredibly pleased to have Asahi on board as a lead investor sharing a common vision to accelerate the sustainability of food production and to future-proof food supply security. The functional nutrition market is evolving rapidly, and the timing of the closing of our Series A financing could not be better. It enables us to bring the unique benefits of our platform technology to market faster. Hence, our customers in the health and nutrition industries can offer products that have a positive impact on the planet and the health of its inhabitants," said Georgios Savoglidis, co-founder and CEO of Embion.

"We see a huge future market in the whole field of upcycling industrial biomass. This area is one of the biggest drivers of transformation in the beverage and food industry. Embion is the leading innovation driver here. We are excited to be a lead investor in the Series A funding round," said Manabu Sami, President and Representative Director of Asahi Quality and Innovations Ltd., which is Asahi’s wholly- owned subsidiary.

Founded in 2016 as a spin-off from the Swiss Federal Institute of Technology Lausanne (EPFL), Embion aims to upcycle 1 million tons of biomass and save 100 million tons of CO2 by 2025. With its catalytic platform technology, Embion delivers innovative and high-value solutions to industry leaders in nutrition and health. Its novel technological approach accelerates the development of functional foods while reducing costs and time to market. Embion is catalyzing the future of nutrition towards a revolution in the bioeconomy.

(Press release)